Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China
Clinical trial NCT01491087 · COMPLETED
Trial details
- NCT number
- NCT01491087
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-07-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.